RecruitingPhase 4NCT04828824

Premature Discontinuation of Contraceptive Implants

Reduction of Premature Discontinuation of Contraceptive Implants by Advance Provision of an OCP-based Participant Intervention: Randomized Clinical Trial

Sponsor

University of Colorado, Denver

Enrollment

600 participants

Start Date

Jun 18, 2021

Study Type

INTERVENTIONAL

Conditions

Contraception Behavior

Summary

To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).

Eligibility

Sex: FEMALEMin Age: 14 YearsMax Age: 23 Years

Inclusion Criteria2

You are between ages of 14 to 22.9 years.
Started etonogestrel implant for the first time and have never used the implant before.

Exclusion Criteria3

There is any contraindication to estrogen containing birth control.
Desire of pregnancy in next 12 months.
Plans to move from the area in next 12 months and is not able to come to the clinic.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEthinyl Estradiol / Norgestimate Oral Tablet

Those who desire COCs as an intervention are prescribed (over the phone) or given (in person) 3 packs of COCs. They are told to take one pill per day until the first pack is complete and save the remaining 2 packs for possible future use.